AstraZeneca’s experimental blood cancer drug gets US priority review
British-Swedish AstraZeneca’s drug for treatment of a form of blood cancer has been granted a Priority Review in the US by the drug.
Drugs
Health
Pharma
Drugs
Health
Pharma
AstraZeneca, Daiichi’s Enhertu drug gets FDA’s priority review in US
AstraZeneca and Daiichi Sankyo got a priority review from the Food and Drug Administration for their Enhertu drug to treat a form of.
Drugs
Health
Pharma
Merck’s vaccine for pneumococcal disease gets FDA’s green light
The US Food and Drug Administration has given the green light to Merck’s vaccine to protect adults against the different types of bacteria.
Drugs
Health
Pharma
Merck gets priority review nod from USFDA for hypertension drug
HQ Team September 28, 2023: Merck’s Biological Licence Application for a pulmonary arterial hypertension drug has been accepted for a priority review by.